Clinical trial
A Multicenter, Randomized, Open-label Clinical Trial Assessing the Efficacy of Octreotide in Decreasing Blood and Iron Requirements in Patients With Refractory Anemia Due to Angiodysplasias
NCT02384122 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Open-label Clinical Trial Assessing the Efficacy of Octreotide in Decreasing Blood and Iron Requirements in Patients With Refractory Anemia Due to Angiodysplasias
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- May 31, 2023
- Enrollment
- 62 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.